id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-312846-ef7m4875	Nerina, Denaro	Coronavirus Disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC)	2020-05-14		.txt	text/plain	825	53	56	In the era of the pandemic the first goal is reducing COVID-19 risk for staff and patients and at the same time ensuring an optimal anti-cancer treatment avoiding delays. Radiation therapy is a life-saving treatment and should be guaranteed to all patients with cancer for whom it is indicated. The treatment plan was modified by prescribing to the boost volume 6 fractions of 3 Gy instead of the planned 10 fractions of 2 Gy. The aim was to achieve a radical dose for the patient but to reduce exposure to the staff of the Radiotherapy department. The choice to continue RT treatment even during COVID 19 infection reflects the most recent indications of the ASTRO-ESTRO Consensus in which it emerged a strong agreement to continue RT in patients with SARS-CoV-2-related mild symptoms who had completed more than two weeks of treatment and an agreement to continue radiotherapy in patients with SARS-CoV-2-related mild symptoms, irrespective to the received treatment at that point. Yom SSPractice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement	./cache/cord-312846-ef7m4875.txt	./txt/cord-312846-ef7m4875.txt